Targeting PSMA by radioligands in non-prostate disease—current status and future perspectives

被引：0
作者：
Philipp Backhaus
Benjamin Noto
Nemanja Avramovic
Lena Sophie Grubert
Sebastian Huss
Martin Bögemann
Lars Stegger
Matthias Weckesser
Michael Schäfers
Kambiz Rahbar
机构：
[1] University Hospital Münster,Department of Nuclear Medicine
[2] European Institute for Molecular imaging (EIMI),Gerhard Domagk Institute for Pathology
[3] University of Münster,Department of Urology
[4] University Hospital of Münster,undefined
[5] University Hospital Münster,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2018年 / 45卷
关键词：
Prostate cancer; PSMA; Prostate-specific membrane antigen; Endothelium; PET/CT; Angiogenesis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：860 / 877
页数：17
相关论文
共 50 条
  • [41] Circulating microRNAs as potential diagnostic biomarkers and therapeutic targets in prostate cancer: Current status and future perspectives
    Movahedpour, Ahmad
    Ahmadi, Nahid
    Ghasemi, Younes
    Savardashtaki, Amir
    Shabaninejad, Zahra
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (10) : 16316 - 16329
  • [42] Cancer biomarker discovery: Current status and future perspectives
    Maebert, Katrin
    Cojoc, Monica
    Peitzsch, Claudia
    Kurth, Ina
    Souchelnytskyi, Serhiy
    Dubrovska, Anna
    [J]. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2014, 90 (08) : 659 - 677
  • [43] Prostate cancer chemoprevention: Current status and future prospects
    Gupta, Sanjay
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2007, 224 (03) : 369 - 376
  • [44] Oligometastatic Prostate Cancer: Current Status and Future Challenges
    Jadvar, Hossein
    Abreu, Andre Luis
    Ballas, Leslie K.
    Quinn, David I.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (11) : 1628 - 1635
  • [45] Chemoprevention of Prostate Cancer: Current Status and Future Directions
    Ronald Lieberman
    [J]. Cancer and Metastasis Reviews, 2002, 21 : 297 - 309
  • [46] Chemoprevention of prostate cancer: Current status and future directions
    Lieberman, R
    [J]. CANCER AND METASTASIS REVIEWS, 2002, 21 (3-4) : 297 - 309
  • [47] Prostate Cancer Registries: Current Status and Future Directions
    Gandaglia, Giorgio
    Bray, Freddie
    Cooperberg, Matthew R.
    Karnes, R. Jeffrey
    Leveridge, Michael J.
    Moretti, Kim
    Murphy, Declan G.
    Penson, David F.
    Miller, David C.
    [J]. EUROPEAN UROLOGY, 2016, 69 (06) : 998 - 1012
  • [48] Prostate-Specific Membrane Antigen-Targeted Radiopharmaceuticals in Diagnosis and Therapy of Prostate Cancer: Current Status and Future Perspectives
    Lin, Mai
    Ta, Robert T.
    Kairemo, Kalevi
    Le, Dao B.
    Ravizzini, Gregory C.
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2021, 36 (03) : 237 - 251
  • [49] Bispecific Antibodies in Prostate Cancer Therapy: Current Status and Perspectives
    Heitmann, Jonas S.
    Pfluegler, Martin
    Jung, Gundram
    Salih, Helmut R.
    [J]. CANCERS, 2021, 13 (03) : 1 - 17
  • [50] Minimally invasive surgery in prostate cancer: Current and future perspectives
    Akduman, B
    Barqawi, AB
    Crawford, ED
    [J]. CANCER JOURNAL, 2005, 11 (05) : 355 - 361
12345